REGENmax Protocol for Cavernous Tissue Regeneration

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current treatments for erectile dysfunction and female sexual dysfunction, such as PDE5 inhibitors, only provide temporary relief and do not address the underlying causes, leading to resistance and progressive impotence, while also affecting penile and female genitalia collagen and oxygenation due to testosterone deficiency and aging.

Innovation Solution

The REGENmax protocol, which includes hormone regenerative therapy, acoustic shockwave therapy, laser treatment, and administration of a tissue regeneration composition, specifically targeting the cavernous tissue and female genitalia to regenerate cells, remodel collagen, and reverse atrophy, thereby restoring full sexual function.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If PDE5 inhibitors are used to treat erectile dysfunction, then temporary erection improvement is achieved, but resistance develops after 2-4 years and root causes remain unaddressed

Engineering Contradiction:

Improveerection sustainabilityVSAvoidtreatment effectiveness duration

Core Design Contradiction:

ReliabilityVSDuration of action of moving object

Solution Approach 1:

The patent applies preliminary action by using low-intensity shockwave therapy before complete impotence sets in, aiming to stimulate angiogenesis and prevent further deterioration of cavernous tissue. The treatment protocol involves multiple sessions over several weeks to proactively regenerate endothelial cells and improve blood flow before the condition becomes irreversible

Inventive Principle:

Principle #10Preliminary action

Solution Approach 2:

The patent employs self-service by activating the body's natural healing mechanisms through shockwave therapy. The low-intensity acoustic waves stimulate endogenous angiogenesis factors (VEGF, eNOS) to promote spontaneous blood vessel formation and tissue regeneration without requiring continuous pharmaceutical intervention

Inventive Principle:

Principle #25Self-service

2Ease of operation

If PDE5 inhibitors are used long-term, then temporary symptom relief is achieved, but collagen degradation and oxygenation issues worsen

Engineering Contradiction:

Improvesexual function restorationVSAvoidcollagen structure integrity

Core Design Contradiction:

Ease of operationVSStability of the object's composition

Solution Approach 1:

The patent replaces the chemical mechanism of PDE5 inhibitors with a mechanical/physical approach using low-intensity shockwave therapy. The acoustic waves mechanically stimulate tissue regeneration, angiogenesis, and collagen remodeling through cavitation and microstreaming effects, avoiding the chemical pathways that lead to collagen degradation

Inventive Principle:

Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes the treatment parameter from chemical inhibition (PDE5 inhibitors) to physical stimulation (low-intensity shockwaves). The acoustic pressure parameters are carefully controlled to stimulate healing without causing tissue damage, transforming the therapeutic approach from symptom management to structural regeneration

Inventive Principle:

Principle #35Parameter changes

3Reliability

If testosterone deficiency is present, then sexual function deteriorates, but collagen degradation and atrophy progress

Engineering Contradiction:

Improvesexual functionVSAvoidtissue firmness

Core Design Contradiction:

ReliabilityVSStrength

Solution Approach 1:

The patent introduces shockwave therapy as an intermediary mechanism that mediates between testosterone deficiency and tissue degradation. The acoustic waves stimulate endogenous production of growth factors and improve blood flow, creating a protective effect that prevents collagen degradation even in the presence of low testosterone levels

Inventive Principle:

Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The REGENmax protocol effectively reverses penile and female genitalia atrophy, restoring full sexual function in 80% of treated patients, with significant improvements in erection sustainability and firmness, even in older patients, and addressing the root causes of erectile dysfunction.

Implementation Method 1

administering acoustic shockwave therapy to the genitalia to generate new vascularity in the genitalia

Methodology Applied

Scientific EffectAcoustic shockwave: Shock Wave

Implementation Method 2

administering acoustic shockwave therapy to the genitalia to generate new vascularity in the genitalia

Methodology Applied

Scientific EffectCavitation: Cavitation

Implementation Method 3

administering a laser treatment to the genitalia

Methodology Applied

Scientific EffectLaser: Laser

Data Source

PatentUS11806301B1Regenerating cavernous tissue to reverse sexual disfunction

Publication Date: 2023.11.07 NUZIARD JEFFREY

AI summary

A treatment that regenerates cells, remodels collagen, and reverses atrophy to restore full sexual function of human genitalia.